Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes after Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial

Naveen L. Pereira, Michael E. Farkouh, Derek So, Ryan Lennon, Nancy Geller, Verghese Mathew, Malcolm Bell, Jang Ho Bae, Myung Ho Jeong, Ivan Chavez, Paul Gordon, J. Dawn Abbott, Charles Cagin, Linnea Baudhuin, Yi Ping Fu, Shaun G. Goodman, Ahmed Hasan, Erin Iturriaga, Amir Lerman, Mandeep SidhuJean Francois Tanguay, Liewei Wang, Richard Weinshilboum, Robert Welsh, Yves Rosenberg, Kent Bailey, Charanjit Rihal

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint Dive into the research topics of 'Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes after Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences